Economic impact of streamlining antibiotic administration

Area of Science:

• Infectious Diseases
• Hospital Administration
• Pharmacoeconomics

Background:

• Hospital-associated infections (HAIs) necessitate complex antibiotic treatment strategies.
• Antibiotic selection and administration involve significant cost considerations for healthcare systems.

Purpose of the Study:

• To evaluate the impact of streamlining antibiotic therapy on cost containment in HAIs.
• To identify opportunities for reducing hospital antibiotic expenditures without compromising clinical outcomes.

Main Methods:

• Analysis of a three-stage therapeutic approach for HAIs.
• Monitoring antibiotic dosing (mode, level, frequency) during different treatment stages.
• Assessing the transition from empiric combination therapy to targeted monotherapy.
• Evaluating the shift from parenteral to oral antibiotic administration for stable patients.

Main Results:

• Empiric therapy is common in the initial three days due to diagnostic uncertainty.
• Streamlining to monotherapy around day four, based on available data, offers cost-saving potential.
• Delayed de-escalation of therapy leads to continued use of expensive empiric agents.
• Switching to oral antibiotics for stable patients can facilitate outpatient treatment and reduce hospitalization costs.

Conclusions:

• Routine assessment of antibiotic management can reduce hospital costs.
• Streamlining antibiotic therapy by adjusting administration mode and frequency is key to cost containment.
• Optimizing antibiotic use balances economic responsibility with effective patient care.